Live Breaking News & Updates on Stefan Riley

Stay updated with breaking news from Stefan riley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Inozyme Pharma To Report Topline Data From Ongoing Phase 1/2 Trials Of INZ-701 In Adults With ABCC6 Deficiency And ENPP1 Deficiency On April 8, 2024

Inozyme Pharma To Report Topline Data From Ongoing Phase 1/2 Trials Of INZ-701 In Adults With ABCC6 Deficiency And ENPP1 Deficiency On April 8, 2024
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United Arab Emirates , United States , Zulf Mughal , Y Joyce Liao , Inozyme Pharma , Matt Pera , Stefan Riley , Exchange Commission , Company Or Inozyme , Corporate Communications , International Number , Company Natural History Study , Inozyme Pharma Inc , Natural History Study , Stanford Medicine , Paediatric Bone Disorders , Specialty Hospital , Webcast Details , Investor Relations , Dial In Number , Trial Design , North America , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Senior Director ,

Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights

– Topline data from ongoing Phase 1/2 trials of INZ-701 in adults with ABCC6 Deficiency and ENPP1 Deficiency expected in early April –– Phase 1 tr. ....

United States , Douglasa Treco , Stefan Riley , Christine Obrien , Inozyme Pharma , Matt Pera , Sagar Nigwekar , European Calcified Tissue Society Congress , Corporate Communications , Exchange Commission , American Society Of Nephrology , Company Or Inozyme , Kidney Research Center , Inozyme Pharma Inc , Development Rd Expenses , Patient Registry , Christineo Brien , Hemodialysis Now Underway , American Society , Kidney Week , Massachusetts General , Early April , Year Ended December , Financial Guidance , Private Securities Litigation Reform Act , Annual Report ,

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Feb. 06, 2024 Inozyme Pharma, Inc. , a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal. ....

United States , Stefan Riley , Matt Pera , Inozyme Pharma , Company Or Inozyme , Corporate Communications , Globenewswire Inc , Inozyme Pharma Inc , Stock Incentive Plan , Nasdaq Listing Rule ,

Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights

– Patient recruitment underway in ENERGY-3 Pivotal Trial of INZ-701 in pediatric patients with ENPP1 Deficiency; topline data expected mid-2025 – ....

United States , Stefan Riley , Douglasa Treco , Inozyme Pharma , Matt Pera , Pamerican Society For Bone , Drug Administration , Inozyme Pharma Inc , Development Rd Expenses , American Society For Nephrology , Paediatric Committee Of The European Medicines Agency , Mineral Research , Corporate Communications , American Society Of Nephrology Kidney Week , Exchange Commission , American Society , Nephrology Kidney Week , Pediatric Patients , Global Impression , England Generation , Generalized Arterial Calcification , Genomics England , Generation Study , Kidney Week , Radiographic Global Impression , Rickets Severity Score ,

Inozyme Pharma Announces Presentation at the American Society of Nephrology (ASN) Kidney Week 2023 - Inozyme Pharma (NASDAQ:INZY)

BOSTON, Oct. 26, 2023 (GLOBE NEWSWIRE) Inozyme Pharma, Inc. (NASDAQ:INZY) ("Inozyme" or the "Company"), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of ....

United States , Inozyme Pharma , Sagar Nigwekar , Stefan Riley , Matt Pera , Research Advances In Bone , Drug Administration , Inozyme Pharma Inc , European Calcified Tissue Society Congress , Corporate Communications , American Society Of Nephrology , Kidney Research Center , Exchange Commission , Mmsc Co , American Society , Kidney Week , Plasma Inorganic Pyrophosphate , Oral Abstract Session , Research Advances , Api Chewcharat , Clinical Fellow , Massachusetts General Hospital , Private Securities Litigation Reform Act , Annual Report ,